Ryan Getzlaf is hosting the 8th Annual Getzlaf Golf Shootout Sept. 8 to raise funds for CureDuchenne and its mission…
Articles by Margarida Azevedo, MSc
Sarepta Therapeutics and Invitae, a company specializing in genetic diagnostics, are expanding a partnership to help clinicians more quickly…
The U.S. Food and Drug Administration recently granted rare pediatric disease designation to Myonexus Therapeutics’ experimental gene therapy MYO-101 for the…
Duchene muscular dystrophy (DMD) patients now have a new scholarship program that could help them pursue their post-high school…
The U.S. Food and Drug Administration (FDA) recently granted fast track designation to Acceleron Pharma’s ACE-083 for the…
A national survey to identify how Americans with disabilities are coping with work and overcoming barriers to employment has found…
Parent Project Muscular Dystrophy (PPMD) has selected PerkinElmer to provide genetic testing for its Decode Duchenne program, which offers…
The Parent Project Muscular Dystrophy (PPMD) is holding its 24th annual conference this year from June 27 to July…
As new diagnostic tools and treatments help patients with Duchenne muscular dystrophy (DMD) live into adulthood, new challenges arise…
Plasticity Brain Centers has become an authorized care provider for children and young adults with muscular dystrophy and other rare…